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Editorial
Leadership: The Secret Ingredient in Delivery System Reform
By David B. Nash, MD, MBA
Editor-In-Chief

In their recent article, The Era of Delivery
System Reform Begins, authors Zirui Song,
PhD, and Thomas H. Lee, MD, trace
the evolution of health care reform in a
series of phases. In phase 1, the insurance
reform mandated by the 2010 Affordable
Care Act (ACA) spurred insurers toward
payment reform (eg, bundled payments)
as an antidote for unsustainable health
care spending. In response, phase 2 saw
reform at the hospital, health system, and
physician group level as they consolidated
into Accountable Care Organizations
(ACO) with the goal of improving
efficiency and quality while reducing costs
for specific patient populations.
Phase 3 – delivery system reform - is where
things get very interesting for those of us
who work in or around the clinical sphere.
This phase focuses on changing the very
culture of medicine, challenging ACO
physician leaders to shift their organizations
away from high-volume/high-cost health
care to lower-cost/higher-value health care.

This newsletter was jointly developed and
subject to editorial review by Jefferson
School of Population Health and Lilly
USA, LLC, and is supported through
funding by Lilly USA, LLC. The content
and viewpoints expressed are those of the
individual authors, and are not necessarily
those of Lilly USA, LLC or the Jefferson
School of Population Health.

Although organizations like Kaiser
Permanente and Geisinger Health
System were designed with cultures that
are compatible with the ACO model,
we lack experience with changing the

culture of organizations that began
life differently. So, recognizing the
formidable challenges inherent in culture
change, where do we focus our approach
to reforming – and transforming - our
health care provider organizations?
The authors suggest 3 important - and,
to my mind, sequential – areas:
•L
 eadership: With bundled payments,
all providers in an organization become
a “team” – like it or not. When one
physician avoids an unnecessary test
and another prevents an unnecessary
visit to a hospital emergency room, it
translates into savings for everyone. It
follows that leaders must understand
and be able to motivate teamwork
and complementary organizational
and professional ethics within the
organization – physician-physician
Prescriptions for Excellence in Health
Care is brought to Population Health
Matters readers by Jefferson School
of Population Health in partnership
with Lilly USA, LLC to provide
essential information from the quality
improvement and patient safety arenas.

(continued on page 2)
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relationships as well as physicianpatient relationships.
• I ncentives: Under health reform,
leaders must shift the organization’s
focus from optimizing individual
physicians’ patient portfolios to
improving the collective value of
the care they provide. A focus on
collective value leads to an increase
in collaboration and consultation
within the organization. It falls
to the organization’s leaders to
design incentives that reward value
through teamwork (eg, measuring
and motivating team performance
on common clinical scenarios).
•R
 ole of the patient: In effect,
ACOs put physicians and patients
on the same team. When the
organization invests in its patients
and integrates their care, both
the physicians and the patients
benefit. Savvy leaders motivate
patients to be active participants
in the organization’s mission.
I could not agree more with the
authors’ conclusion that modern

provider organizations must provide
leadership for culture change and a
health care system with a common
vision. With the help of patients,
payers, and a legal system that protects
physicians who refuse to prescribe
unnecessary products or deliver
unnecessary services, organization
leaders and governing boards will
see us through phase 3 and into a
transformed US health care system.

With the ACA firmly in place and
the ACO model gaining traction,
the second article “Corporate
Governance, Health Care Quality, and
Accountable Care,” takes a look at the
complexities of multi-organization
boards and the additional oversight
challenges they pose. The author
of the third article shares keen
insights into the payer perspective
on governance and offers thoughtful
answers to the question, “Why Insurers
Are Investing in Hospital Trustees.”

As I reviewed the articles for this issue
of Prescriptions for Excellence in Health
Care, I was struck by the common
thread of leadership. In essence, all
governing board members commit
to a leadership role that creates and
maintains a culture of quality and
safety throughout their organizations.

The final article, “The Future of
Governance: Accountability for CustomerCentered Care and Population Health
Oversight,” is a compelling narrative that
describes the evolving role of boards as
care moves outside of hospital walls and
becomes more patient-centric over the
coming decade.

The first article, “Staffing the Board
Quality and Patient Safety Committee:
One Health System’s Experience,” is
an in-depth account of how a small,
forward-looking health system
has gone about building a strong
connection between its governing
board and the quality of care across its
multiple settings.

As always, I look forward to hearing
from our readers. I can be reached at:
david.nash@jefferson.edu.
Reference
1. Song Z, Lee TH. The era of delivery system reform begins.
JAMA. 2013;309:35-36.

Staffing the Board Quality and Patient Safety Committee:
One Health System’s Experience
By Denise Murphy, RN, MPH
Introduction
The Getting Boards On-Board guideline
published by the Institute for Healthcare
Improvement (IHI) in 20081 encouraged
health organization governing bodies to
create committees focused exclusively on
quality of care and patient safety (QPS).
In partnership with the chief executive
officer (CEO) and chief medical
officer (CMO), an organization’s QPS
executives often bear responsibility for

staffing the board’s QPS Committee.
This article relates the experience of
Main Line Health (MLH), a 6-hospital
nonprofit health system serving portions
of Philadelphia and its western suburbs.
MLH and its hospitals consistently
achieve industry recognition for quality
and safety excellence.
The MLH Board of Governors delegates
oversight for QPS to a 15-member

committee comprised of governors,
medical staff leaders, and senior
executives, and is chaired by a physician
QPS expert from Jefferson’s School of
Population Health. The board and its
QPS Committee meet 6 times annually.
Committee responsibilities include:
• Ensuring high-quality health
care through oversight of quality
assurance and risk management

This newsletter was jointly developed and subject to editorial review by Jefferson School of Population Health and Lilly USA, LLC, and is supported through funding by Lilly USA, LLC.
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processes and results, monitoring
patient satisfaction, and approving
new programs and services
• Approving strategies for health
care provision
• Ensuring medical staff
accountability and oversight of
credentialing processes
• Approving medical staff
bylaws, rules, and regulations,
and confirming administrative
appointments
• Evaluating medical executive
committee recommendations to
the board
• Evaluating medical staff roles in
meeting community health needs
• Evaluating issues pertaining to
consolidation and integration of
clinical services
• Evaluating future clinical
service needs
• Advising the board on other issues
relating to QPS.
Orientation of New QPS Committee Members
Each year, the QPS Committee chair,
CMO, and vice president for QPS
orient new committee members to their
roles in the context of the health care
quality environment that encompasses
both external elements (eg, standards,
regulations, economics) and internal
drivers for improvement (ie, performance
metrics, patient safety events, results
of cause analyses, staff perceptions
about safety culture, patients’ responses
to satisfaction surveys). The QPS
Committee reviews national, state,
regional, and internal infrastructures as
well as priorities and major initiatives
aimed at improving patient care quality,
safety, and satisfaction.

QPS Committee members invest
significant time in preparing for and
attending meetings, and they are
gratified by evidence that their intense
focus on and active involvement
in QPS yields positive results. The
literature suggests that organizations
produce better outcomes when they: (1)
spend more than 25% of their time on
QPS, (2) receive a formal measurement
report, (3) tie executive compensation
to QPS performance metrics, (4) have
a high level of interaction with medical
staff, and (5) identify their CEO as
the person having the greatest impact
on QPS.2 Relevant articles and the
IHI’s Boards On-Board document are
included in the orientation electronic
materials packet.
Orientation leaders present the
IHI’s “Six Things All Boards Should
Do” (Table 1) and discuss how
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management will go about meeting
its responsibilities related to joint
goal setting, agenda priorities,
the process for metric review, and
selection of board education topics.
QPS Committee members receive an
iPad and instructions on how to use
the Board Effect (BoardEffect Inc.,
Philadelphia, PA) application where
materials are posted 2 weeks prior to
each meeting. Issues of confidentiality
and sensitivity related to patient-level
information and peer-review protection
are covered. Also, MLH’s commitment
to a safety culture requires that the
board meet periodically with a patient,
family, and/or staff member who was
involved in a recent harm event.
Setting Goals and Priorities on the
Annual Agenda
The most challenging governance
functions we have encountered include

Table 1. Six Things All Boards Should Do
1. S
 et a specific aim to reduce harm this year and make an explicit, public
commitment to measurable quality improvement (eg, reduction in
unnecessary mortality or harm).
2. S
 elect and review progress toward safer care as the first agenda item at every
meeting. (Get data on harm and hear stories; put a “human face” on data.)
3. E
 stablish and monitor a small number of organization-wide “roll-up”
measures that are updated continually and are transparent to the entire
organization.
4. C
 ommit to establish and maintain an environment that is respectful, fair,
and just for all who experience pain and loss from avoidable harm.
5. D
 evelop the capability of the board:
•L
 earn how “best in the world” boards work with executive and physician
leaders to reduce harm.
•S
 et an expectation for similar levels of education/training for all staff.
6. O
 versee the effective execution of a plan to achieve the board’s aims to
reduce harm, including executive team accountability for clear QPS targets.
Source: Conway J. (Institute for Healthcare Improvement, Cambridge, Massachusetts, USA) 2008.

(continued on page 4)
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(1) acquiring sufficient understanding
of performance metrics to enable
diligent oversight, and (2) setting annual
goals. MLH’s QPS dashboard, with
its stoplight format aligned with the
Institute of Medicine’s (IOM) 6 aims
for quality (ie, safe, timely, effective,
efficient, equitable, patient-centered),3
is first presented in depth at orientation.
The goal selection process and source
data for targets and benchmarks are
among the topics reviewed.

staff also receive monetary rewards if
patient experience/satisfaction targets
are met.
The top priority, eliminating
preventable harm, emerged from an
organizational commitment to embed
a reliable culture of safety, measured by
a 50% reduction in preventable harm

each year until zero harm events are
achieved and sustained for at least 12
months. Because there is no nationally
accepted definition for preventable,
MLH defines it as “harm resulting
from a deviation in generally accepted
practice standards” and classifies
serious safety events (SSE) in terms
of level of harm. The algorithm used

Figure 1. Algorithm for Determining Preventability of Safety Events

Goals are specific, measurable, and
achievable (the “threshold”), timely
based on current national comparisons
(the “target”), and challenging.
Top decile performance against
national comparisons (“maximum
performance”) is the stretch goal
for all measures. With over 40 QPS
indicators routinely monitored,
the management team assumes
responsibility for facilitating the
board’s selection of its own priority
focus for quality (“performance”)
improvement initiatives.
Of MLH’s top 10 performance
improvement priorities (eg, harmful
events such as health care-associated
infections, falls, pressure ulcers,
adverse obstetrical events), the QPS
Committee selected the following for
intense focus in 2012: (1) eliminating
preventable serious safety events, (2)
reducing sepsis-related mortality, (3)
reducing avoidable readmissions, and
(4) improving patient satisfaction.
These 4 strategic priorities are aligned
with executive compensation; some are
aligned with medical staff incentive
programs. For example, hospitalists
are now incented to drive efforts
to reduce avoidable admissions,
ensure compliance with the sepsis
protocol, and to improve patient
satisfaction scores; specifically, the
“Communication with Physicians”
component. Managers and frontline

Source: Modified from algorithm provided by Healthcare Performance Improvement (HPI, Virginia Beach, VA 2011).

Figure 2. Main Line Health Preventable Harm Serious Safety Events, May 2011 – April 2012
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to determine preventability (Figure
1) is explained during committee
orientation and included in each
meeting packet thereafter to promote
sustained knowledge about safety
event designations.
The SSE rate is displayed as both
a 12-month rolling rate per 10,000
adjusted patient days, as well as a
bar graph designating the number
of patients harmed (Figure 2). The
SSE rate is presented at each QPS
Committee meeting along with results
of cause analyses and action plans to
prevent similar events in the future.
Patient stories are coupled with each
data point.
The CEO hosts annual retreats with
the full board to engage in strategic
planning, review accomplishments
against goals, discuss opportunities for
improvement, and set the QPS agenda
for the upcoming year. This retreat
also sets the direction for bimonthly
meeting agenda planning.
Prevention and Performance
Improvement: Where the Rubber
Meets the Road
As part of a Pennsylvania Safety
Culture Collaborative, MLH engaged
with Healthcare Performance
Improvement, LLC to better
understand reliability science, to
conduct more informative accident
causation analyses, and to calculate
an SSE rate to track preventable
harm. Training on leader methods
for reliability and safety behaviors
supported by error prevention tools
involve all direct and indirect care
providers, physician and administrative
leaders, as well as the board (Tables 2a
and 2b).
Physicians, nurses, and executive
leaders present patient safety stories,

5

The Main Line Health

Table 2a. The
Main Line Health
Reliability Culture
Toolkitfor
for Leaders
Reliability
Culture
Toolkit
Leaders

Behaviors
Make Safety a Core Value
We put patient safety first by using our
first words for patient safety. We ask
the safety question first, and we ensure
that good things always happen to
those who speak-up for safety.

Tools
1. Start every meeting with a
safety topic or story
2. Recognize & support people
who ask the safety question or
“stop the line for safety”
3. Transparency in sharing safety
events
4. Embed safety in hiring and
performance reviews
5. Encourage and reward
reporting of safety events –
eliminate fear of reporting

Find & Fix System Problems
We improve patient care every day by
fixing system problems before they find
us. We are sensitive to operations,
identify problems that make safe
patient care difficult to deliver, and
solve the causes of those problems.

Build Accountability
We make reliability a reality by
building sound practice habits in our
staff. We reinforce sound practice
habits, we discipline those who make
risky choices, and we never punish
those who experience honest mistakes.

1. Daily Check-In
2. Start the Clock for Safety
3. Brief / Execute / Debrief

1. 5:1 feedback
2. Rounding to Influence
3. Just Culture
4. Red Rules

sharing event details, results
of
CMO
and vice
president for
Where
SafetyThe
is our
Main
Line
cause analyses, “Great Catches,” and
QPS meet routinely with the chair
action plans for prevention with the
of the QPS Committee of the board
board. Explanations of harm or near
to plan meeting agendas and, more
miss events include use of reliability
importantly, to identify timely topics
methods, safety behaviors, and error
of interest for board education.
prevention tools that would have
For example, a recent presentation
prevented an event occurrence. Direct
highlighted the MLH strategy
discussion with those involved in safety
to prepare for bundled payments
events results in better understanding
through creation of “clinical excellence
for committee members and a deeper
bundles” for total joint and cardiac
sense of shared accountability for
procedures, as well as for patients
quality of care and patient/staff safety.4
with heart failure and respiratory
(continued on page 6)
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conditions. Review of implementation
progress and sustainability of patient
safety action plans and performance
improvement initiatives are also part
of these planning meetings. Lean Six
Sigma teams are invited to share results
with board members during the “deep
dive” into dashboard metrics that
fall short of target goals. Teams that
have achieved maximum performance
goals also are invited to celebrate their
accomplishments and lessons learned
with the board.
Denise Murphy, RN, MPH, is Vice
President for Quality and Patient Safety
at Main Line Health System. She can be
reached at: MurphyD@MLHS.org.
References
1. Institute for Healthcare Improvement. Getting boards
on-board: leadership engagement key to reaching quality
goals. http://www.ihi.org/knowledge/Pages/Publications/
GettingBoardsonBoardLeadershipEngagement.aspx.
Accessed January 23, 2013.
2. Vaughn T, Koepke M, Kroch E, Lehrman W, Sinha S,
Levey S. Engagement of leadership in quality improvement
initiatives: executive quality improvement survey results.
Journal of Patient Safety. 2008;2:2-9.
3. Institute of Medicine. Crossing the quality chasm: the
IOM health care quality initiative. http://www.iom.edu/
Global/News%20Announcements/Crossing-The-QualityChasm-The-IOM-Health-Care-Quality-Initiative.aspx.
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4. Conway J. Getting boards on board: engaging governing
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2008;34(4):214-220.

The
Error
Prevention
Table 2b.
The Main
Main LineLine
Health Health
Error Prevention
Toolkit

Toolkit

I commit to the following…

By Practicing the Following…

Safety Behavior Expectations

Error Prevention Tools

Attention to Detail
We focus our attention to always think
before we act, especially in high risk
situations.

 Self Checking Using STAR
Stop
Think
Act
Review

Communicate Clearly

 3-Way Repeat Back & Read Back

We’re responsible for professional, clear,
and complete verbal and written
communications.

Handoff Effectively

 Phonetic & Numeric Clarifications
 Clarifying Questions

We provide effective handoffs of patients,
tasks, and materials by taking the time to
give appropriate information and
ensuring understanding and ownership.

 Use SBAR to handoff:
Situation
Background
Assessment
Recommendation

Speak up for Safety

 Crucial Conversations

We use good judgment at all times to
ensure our actions are the best. We use
an assertion and escalation technique to
act on our responsibility to protect
patients & co-workers in a manner of
mutual respect.

 Question & Confirm
 Use ARCC to escalate safety
concerns
- Ask a Question
- Make a Request
- Voice a Concern
- Use Chain of Command
 Stop the line for immediate risk!

Got Your Back!
We make reliability a reality by building
our own sound practice habits and in our
co-workers. We’re accountable not just
for our own actions but for our
teammates’ as well.

 Peer Checking
 Peer Coaching

Where Safety is our Main Line

Corporate Governance, Health Care Quality, and Accountable Care
By Douglas A. Hastings
Corporate Governance Developments
The past decade has seen a revolution
in corporate governance and in the
expectations set for corporate directors.
Fiduciary duty has come to mean that
directors must be active participants in
oversight, not mere passive recipients
of information. A good director
must engage in active inquiry and be

demanding enough to rattle cages when
necessary; be knowledgeable enough to
set direction; be bold enough to add value
through hard questions; and be vigorous
enough to assure that the organization’s
plans yield results. Yet, a director must
not lose sight of the difference between
oversight and day-to-day management.

Fiduciary Challenges and Opportunities in
the Accountable Care Era
Health care provider organizations
face a variety of challenges and
opportunities in the accountable care
era. As fiduciaries, board members
must address several key issues in
this period of payment reform. Feefor-service payments are likely to
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decline steadily in the years ahead,
challenging financial performance.
Additional payment changes will
further reduce reimbursement to
providers who score poorly on quality
measures or who evidence inefficiencies
such as above-average readmissions.
The shift to various forms of pay
for performance, bundled payments,
global- or population-based payments,
and other value-based reimbursement
methodologies will require infrastructure
investments by providers that may
or may not be reimbursed, further
threatening financial solvency.
With the increasing focus on quality
measurement and reporting, boards
are faced with the prospect that these
initiatives may uncover indications of
fraud and abuse and trigger judgments
against providers making claims to
public and private payers for care that
is ultimately deemed substandard.1
Expanded quality data reporting and
transparency requires board oversight to
assure that the reports are accurate and
that compliance plans are enhanced to
address these expanded concerns. It is the
responsibility of a provider entity board
to review the organization’s committee
structure to ensure that the board and/
or board committee’s charter specifically
requires attention to effectiveness,
efficiency, and patient-centeredness in
addition to patient safety.
Finally, Accountable Care Organization
(ACO) boards and ACO sponsoring
organization boards must ensure that
appropriate and effective management
of clinical personnel and protocols are in
place to meet the Centers for Medicare
and Medicaid Services (CMS), National
Committee for Quality Assurance
(NCQA), and other requirements and to
achieve the ACO’s quality and financial
goals. Health systems and physician
organizations seeking to create ACOs

must consider which entity – one that
currently exists or one to be formed –
will serve as the ACO (including how
many ACOs it may want to form or
work with) and how to coordinate the
ACO board or boards with other boards
within the health system.
Medicare Shared Savings Program Final
Rule – Structure and Governance2
The formation of a new entity to serve
as a Medicare ACO is not required if
an existing entity (or entities) meets all
of the applicable requirements set forth
in the rule. The ACO governing body
nevertheless must include participating
ACO providers and suppliers (or
representatives) and Medicare
beneficiaries (or representatives) – at
least 75% control of the governing body
must be held by ACO participants
(providers and suppliers).
The Final Rule removed the Proposed
Rule’s controversial requirement that
each ACO participant must have
“appropriate proportionate control over
governing body decision making.”3
The Pioneer Model includes an
additional requirement that the ACO
board include a “consumer advocate.”
These governance representation
requirements raise questions about
the fiduciary duty of ACO governing
boards (ie, governing board members’
allegiances generally will be to the
ACO rather than to the particular
providers or groups they represent).
NCQA ACO Accreditation Guidelines –
Governance4
NCQA scores an ACO on the
effectiveness of the role, structure,
and functions of its governing body,
including, “how well the governing
body provides leadership, establishes
accountability and provides the
structure to align the functions of an
ACO.” NCQA criteria state that the
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designated physician or clinician leader
of the ACO “must participate on or
advise the board” or “have a substantial
management function.” NCQA also
requires an ACO to have a documented
process for annually reviewing the ACO’s
performance and the ACO governing
body’s performance. ACO governing
bodies also must assure that the
following stakeholder groups are involved
in its oversight functions: primary care
practitioners and specialists who provide
care for the ACO’s patients; hospitals
that provide care for the ACO’s patients;
consumers (eg, individual patients,
consumer organizations) who do not
have a financial or business stake in the
health care system; and purchasers.3
Balancing Representational Requirements
ACO boards must balance stakeholder
representation (required by CMS
or NCQA) with Internal Revenue
Service (IRS) requirements related
to community representation, when
applicable, as well as with both IRS
and good governance recommendations
related to the need for a reasonable
number of “independent” directors on
boards. Ultimately, the director’s job is
not to “represent” a particular faction
or constituency in exercising oversight
in accord with the duty of care; rather,
a director must act in the overall best
interest of the organization for which
he or she is a fiduciary. This differs
from duty on an advisory board or duty
as a provider representative viewing a
contract negotiation with a payer or
another provider. ACO sponsoring
organization board members and
ACO board members must clarify
their respective missions, visions, and
goals - and understand the differences
between them.
Governance in the Accountable Care Era
Focused, intentional governance in
the accountable care era calls for
(continued on page 8)
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board members to be both educated
and proactive. This requires robust
recruiting and educating of directors
with the right skill sets; providing
ongoing information that is incisive and
detailed enough to allow for effective
oversight without excessive, unnecessary
detail; and having in place evaluation
mechanisms that allow the board to
continuously improve its performance.
Key areas of board oversight in the
accountable care era include measuring
and managing value, maximizing patient
and physician stakeholder engagement,
enhancing outcomes reporting
transparency, strengthening internal
pay-for-performance programs while
remaining legally compliant, and making
the board’s work more intentional.
Making the Board’s Work More Intentional
It will not be easy to attract, engage,
and retain superior board members
in this new era of high-performance
governance. For board members to
believe their time and talents are
being maximized, new cultures and
systems must be developed to govern
tomorrow’s integrated and accountable
care delivery systems.

High-performance boards must
continuously explore and practice
intentional governance that embraces
attributes such as:
1. Competency-based governance by
means of recruiting and educating
diverse and talented board members
to achieve a balanced set of skills,
attitudes, and experience within the
board and its committees, advisory
councils, and task forces.
2. Information for governance decision
making that is driven by data from
electronic health records, episodes
of care cost profiles, and satisfaction
scores of patients, physicians,
employees, and purchasers.
3. Fewer but smarter meetings with
agendas that encourage meaningful
conversations with expert speakers,
clinicians, middle managers, and
industry analysts about strategic
challenges and future opportunities,
rather than reviewing past statistics.
4. Patient stories that ground and
inform the board’s deliberations
about the reality of clinical

frontline challenges and the
continuous call for value from care
that is convenient, comfortable,
customized, and cost-effective.
5. Governance processes and
structures that are evaluated
each year to develop “governance
enhancement plans.”
Accountable care demands accountable
governance. Great boards must engage in
critical conversations about governance
best practices in their journey toward
continuous governance improvement in
the accountable care era.
Douglas A. Hastings is Chair, Board of
Directors at EpsteinBeckerGreen. He can
be reached at: Dhastings@ebglaw.com.
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Why Insurers Are Investing in Hospital Trustees
By Christine Izui
Trustees are positioned to lead sustainable
delivery system transformation to advance
the organization’s mission. Insurers
can help promote such transformation
by modifying external incentives and
payment levers. Insurers, such as Blue
Cross and Blue Shield (BCBS) health
plans, invest in trustee education as a step
toward effective dialogue and eventual
progress on mutual goals to improve the
health care delivery system.
Mutual goals, robust data, and a
trusting relationship are essential for

experimentation with payment and
delivery system change. The realm of
patient safety, with its well-understood
aims and specific performance metrics, is
an excellent starting point for leadership
discussions between insurers and health
care providers to align goals for payment
and system reform.
Although current payment approaches
and corresponding educational needs
of leaders are evolving rapidly, calls for
payment reform to promote higher
quality of care are hardly new. More

than a decade ago, the Institute of
Medicine’s Crossing the Quality Chasm
series of reports recommended removing
payment barriers to quality improvement
through experimentation and pilot
programs.1 More recently, the 2012
National Quality Forum’s Report to
Congress indicated that substantial
changes are needed to care delivery and
payment if we are to meet the National
Quality Strategy aims of “healthy people
and communities, better care, and more
affordable care.”2
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Removing barriers to make way for
new care processes is daunting work.
Invariably, new payment models result
in anticipated (and unanticipated)
changes in the roles and performance
of health care providers along the
continuum of the health delivery
system. The dynamics of such change
must be understood by insurers and
hospital leadership alike to assure that
the welfare of patients remains central
to processes that promote high-quality
care. Motivated trustees must have
rich clinical-financial information
and the appropriate skills to create
strategic goals and internal incentives
to transition the delivery system to
one that meets the needs of the larger
public served by the organization.
Historically, the health care industry
has not invested in its leaders. In a
2008 article, Conway describes how
hospital boards can mobilize to create
an agenda for the ambitious aims of the
Institute for Healthcare Improvement’s
5 Million Lives Campaign.3 In addition
to numerous goals focused on changing
care at the bedside, the campaign stressed
education and engagement to “get ‘boards
on board.’” BCBS health plans made
financial investments to support the
campaign and also urged hospitals to join.
Some remarkable results have been
achieved in addressing quality and safety
issues, such as widespread adoption of
methods to end infections.4 However,
there is evidence that these practices
are not being disseminated throughout
organizations. For example, a successful
intervention in an intensive care unit is
not always disseminated to other areas
of the hospital where a central line
infection may occur. Checklists used in
one operating suite may not be adopted
by surgical teams in other surgical suites
within the same hospital. It is incumbent
upon leaders to create a strong message

and a clear path to institutionalize a
successful campaign activity and create a
sustainable safe patient environment and a
culture of continual quality improvement.
Educated trustees are critical to creating
an environment of positive change within
the organization. A number of BCBS
health plans have worked with local
hospital associations to provide education
as a step in heightening awareness about
patient safety, quality, and payment
incentives. For example:
•

•

BC of Idaho adopted contract
language around specific quality
metrics such as readmissions,
pressure ulcer rates, and surgical
safety, as well as trustee education.
Education provided by the hospital
association is open to the hospital
leadership team, with an emphasis
on bringing hospital trustees up to
speed on their roles in changing
the organization. To leverage this
education, BC of Idaho requires
that hospitals submit board agendas
and quality summaries from
meetings to BC of Idaho quality
staff. In addition, best practices are
disseminated from one hospital to
other hospitals in Idaho.5
In South Carolina (SC), the
educational model “Best on Boards”
includes training, testing, and
certification.5 BCBS of South
Carolina supported this program
by underwriting the cost of those
attending the training and providing
a financial incentive for hospitals
with a high percentage of board
members certified. Of note, SC
embarked on a statewide surgical
improvement effort with many
stakeholders involved in dialogue
and oversight.6 Trustees must
develop their abilities to understand
performance data, statewide goals,
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individual hospital goals, available
tools, and barriers to improvement.
•

BCBS of Massachusetts supports
trustee education and also is
working to change financial
incentives through Alternative
Quality Contracts, which
link a hospital’s rate of pay to
demonstrated performance on
quality and cost benchmarks.7

Trustee education is just a starting point.
Trustees must become highly engaged in
understanding new metrics of success in
payment approaches. As we move into
an era of “No Outcome, No Income,”8
organizations must understand the new
expectations. The pace of experimentation
is picking up with the creation of smaller
center-of-excellence networks that
exclude many hospitals; implementation
of episode-of-care processes and payments
that span time periods and provider
settings; growth of the patient-centered
medical home model; introduction of
pathways for oncology and other complex,
expensive treatments; and transfer of
financial risk to providers who are in a
position to manage the care.9
Insurance companies are increasingly
aware of the waste created by poor
quality. Several organizations are trying
to quantify the amount of waste and the
dollars that could be saved if adverse
events were avoided.10,11 The numbers
are staggering, with one organization
identifying $600 billion in potential
cost savings by eliminating unexplained
variation in the intensity of medical
and surgical services (eg, end-of-life
care, percutaneous coronary procedures)
without adversely impacting quality of
care.12 Opportunity exists for trustees,
executive leadership, and insurers to
collaborate on ambitious but responsible
performance goals and financial rewards
aimed at reducing medication errors,
(continued on page 10)
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surgical complications, readmissions,
infections, and other problems that arise
during medical care.
Organization leadership must prioritize
the need for and the direction of change
to assure alignment with its mission,
staff motivation, and dissemination
of best practices. Insurers can help by
suggesting changes, requiring performance
reporting, and tying financial incentives
to performance. Well-informed trustees
can guide organizational change using
robust intelligence on financial and
clinical performance, an understanding
of changing payment incentives, and
an appreciation of the organization’s
competencies. In an evaluation of major
reasons for joining an organization’s
board, Martin concluded that the “only
worthy motivation” comes from a desire
to perform public service.13 Trustees are
ideally positioned to keep patient and
community needs front and center as
financial and delivery system changes

unfold. Insurers can be valuable partners in
setting appropriate incentives for achieving
performance goals and demonstrating a
commitment to improvement.
Christine Izui is the former Executive
Director of Quality and Safety in the Office
of Clinical Affairs Division of the Blue
Cross and Blue Shield Association. She can
be reached at: izuichris@gmail.com.
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The Future of Governance: Accountability for Customer-Centered Care and Population
Health Oversight
By Kathryn C. Peisert
To prepare for new payment models,
hospitals and health systems must
intensify their focus on improving
quality while reducing costs. As
care becomes more integrated and
reimbursement becomes more closely
linked to patient outcomes at the “end”
of the care continuum, boards must
expand the scope of their oversight
to include care settings outside the
hospital. Such expansion adds to
the complexity of governance, with
implications for redefining the board’s
role in coordination with medical
groups, post-acute care organizations,
and other nonhospital providers.

Three premises address the question of
how hospital and health system boards
will be required to govern and oversee
quality of care over the coming decade as
the transition to value-based care is more
fully realized:
1) Boards will influence care provided
outside of the hospital setting.
2) As new research yields evidence for
effective governance, boards will
be able to practice evidence-based
governance.
3) Increasingly, boards will govern care
that is centered on the customer

and, in effect, will oversee the health
of the populations they serve.
A Transitioning Market Moving Care
Outside the Hospital
Essentially, care delivery transformation
is being dictated by new federal
government payment models and new
arrangements with private payers that
reward value and include varying degrees
of shared risk, (eg, bundled payments,
pay for performance, accountable care
models). These changes provide a
compelling business case for the board
to be deeply involved in quality of care.
Consider the bundled payment model
wherein a single payment is generated
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for an entire episode of care. The single
payment must be distributed among all
providers who “touched” the patient. If
the hospital provides effective care for a
given patient, and that patient receives
inappropriate care at a post-acute facility
that negatively affects the outcome, the
single payment is lower. This example
demonstrates the pressure on boards to
examine quality and cost, and to create
accountability for how care is delivered
in other settings. The business case for
focusing on quality has never been clearer.
Care delivery must focus on wellness and
prevention, increased quality and safety,
and reduced costs. Examples include
allowing more care to be provided on
an outpatient basis, using physician
extenders and other nonphysician
providers, reducing unnecessary/
duplicative tests and treatments,
increasing the use of evidence-based
processes and protocols, improving care
coordination (transitions within the
hospital and transitions from one care
setting to another), and improving the
management of patients with chronic
diseases. Organizational integration/
alignment (via employment, partnerships,
or other accountable arrangements)
with physicians will be critical. The new
culture at the bedside will dictate changes
in the information boards use to assess
quality of care and will exert pressure on
boards to ensure that their governance
practices make a clear difference at the
front lines of care.
Board Practices That Affect Outcomes
Increasing calls from the industry for
standardized provider protocols and
evidence-based practice beg the question
of whether evidence can be found
to connect board activities to quality
outcomes. The small amount of research
on this topic, dating back to 2005,
shows statistical correlations between
board practices in quality oversight and
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care outcomes.1 However, results have
been inconsistent and studies have been
limited to board practices in the area of
quality oversight.

•T
 he board spends more than half of
its time during most board meetings
discussing strategic issues as opposed
to hearing reports.

A new study conducted by The
Governance Institute and National
Research Corporation Healthcare
Analytics2 matches responses regarding
adoption of board practices from The
Governance Institute’s biennial survey
of hospitals and health care systems to
performance on the inpatient processof-care quality measures included in the
Centers for Medicare and Medicaid
Services Value-Based Purchasing
program. Of 101 board practices, the
analysis identified 14 with a statistically
significant difference in the proportion of
high-performing hospitals adopting the
practice versus low-performing hospitals.
Examples of those practices are:

• The

board has adopted policies and
procedures that define how strategic
plans are developed and updated,
such as who is to be involved, time
frames, and the role of the board,
management, physicians, and staff.

•T
 he board requires major hospital
clinical programs or services to
meet quality-related performance
criteria, such as volume requirements,
effective staffing levels, and
accreditation.
•T
 he board has adopted a
policy concerning reporting the
organization’s quality/safety
performance to the general public.
•T
 he board uses competency-based
criteria when selecting new board
members.
•T
 he board uses an explicit process of
board leadership succession planning
to recruit, develop, and choose future
board officers and committee chairs.
•T
 he board participates in the
development and/or approval of
explicit criteria to guide medical staff
appointments, reappointments, and
clinical privileges.

Although this research sheds some
light on practices that seem to affect
process-of-care measures, future studies
are needed to replicate these results,
demonstrate improvement over time,
and delve into reasons why these specific
practices are revealed in this analysis
rather than others. With increased
understanding, boards can restructure
their work over time to enhance specific
areas of oversight. As we ask physicians
to practice evidence-based medicine, we
also should consider the possibility of
practicing evidence-based governance.
Governing Customer-Centered Care and
Population Health Management
Along with research leading to evidencebased governance, continuing studies also
must explore the expansion of the board’s
role into customer-centered care and
population health management.
Boards must lead hospitals and health
systems into the new realm of value, a key
component of which is customer-centered
care. Care that supports patients’ needs
and preferences also supports patient
compliance and improved outcomes.3
Beginning in October 2012, 30% of
Medicare reimbursement became tied to
certain Hospital Consumer Assessment of
Healthcare Providers and Systems patient
satisfaction measures. As care becomes
centered on the customer, organizational
strategy and mission must broaden to
encompass actions that target improved
(continued on page 12)
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access points, care coordination, medical
homes, and staff training on customer
experience issues. Likewise, the quality
measures used by boards must evolve
along with credentialing and privileging
policies.
Beyond physician employment and
integration, fewer physicians will
continue to practice in hospitals and
physician extenders and nurses will take
on more hospital care. Again, outcomesbased reimbursement will be based on
the quality of care delivered across all
settings. Governance considerations
include updating criteria and process for
physician reappointment to the medical
staff, evaluating physician adherence to
standardized protocols and procedures,
and assessing individual providers’ care
delivery and outcomes in various settings.
Another component in addressing
quality and cost, population health
management will be a key element in

redirecting focus toward coordinating
and improving care for populations at
highest risk of poor health and those
with costly chronic diseases. With this
in mind, boards must: identify and
focus on improving the health status
of key patient populations, create
interdisciplinary care teams to coordinate
this care, engage physician leaders in this
effort, and create a new culture centered
around customer-centered care and
population health.
The Future of Governance
Going forward, new best practices
will emerge related to overseeing care
delivered outside the hospital setting.
Accountable governance models will
develop and evolve as accountable
care organizations take shape. New
and enhanced roles for physicians and
nurses will be created in leadership and
governance to provide oversight and
clinical expertise - and also to help define
this new model of governance.

As a result, there may be a rise in joint,
collaborative governing boards that
contain a mix of clinicians, population
health specialists, and nonclinician quality
experts to oversee hospitals, clinics,
medical groups, and medical homes. As
continued research evidence informs
improvement and supports governance
practices, boards eventually will be able to
practice evidence-based governance.
Kathryn C. Peisert is Managing Editor
of The Governance Institute. She can be
reached at: kpeisert@governanceinstitute.com.
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